Prokarium to create new oral vaccine delivery tech

- Last updated on GMT

Prokarium – a biotech company that was formerly part of UK CMO Cobra Biologics spin-out - has bought an oral vaccine technology from Emergent BioSolutions.

The platform includes is a live Salmonella​-based typhoid vaccine Typhella and genetic technology spi​-VEC ​developed by Emergent. Prokarium will combine this with its own ORT-vac expression platform to create an oral vaccine delivery platform, named Vaxonella.

Prokarium plans to license the delivery platform to other biotechnology companies, while its in-house team will use it to develop a dual oral vaccine against typhoid and travellers’ diarrhoea.

Related topics: Drug Delivery

Related news

Show more